Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 14, 2016
Accession Number: 0001193125-16-737631
Submission Type: POS AM
CIK: 0001401914
Company Name: Cerulean Pharma Inc.
File Number: 333-206396